Constantinos Loizou has been CEO/Founder of EMBIO Diagnostics since 2016 and holds an M.Sc. and an M.Eng. from the Technical University of Crete. He has grown EMBIO to a multimillion valuation and received various awards from organizations such as Microsoft and EBRD.
Constantinos secured financial support from private investors in Cyprus at a level that only a few companies have managed. In 2021 he was hosted in multiple national media - especially due to EMBIO's adoption and successful development during the Covid-19 pandemic. His mission is to deliver innovation to the market through portable diagnostics and data insights.